183 related articles for article (PubMed ID: 27939474)
21. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
Yu J; Shixia CZ; Wu Y; Duan T
Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
[TBL] [Abstract][Full Text] [Related]
22. Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes.
Stamatopoulou A; Cowans NJ; Matwejew E; von Kaisenberg C; Spencer K
Hypertens Pregnancy; 2011; 30(4):384-95. PubMed ID: 20701472
[TBL] [Abstract][Full Text] [Related]
23. Plasma mRNA concentrations of placenta-specific 1 (PLAC1) and pregnancy associated plasma protein A (PAPP-A) are higher in early-onset than late-onset pre-eclampsia.
Kodama M; Miyoshi H; Fujito N; Samura O; Kudo Y
J Obstet Gynaecol Res; 2011 Apr; 37(4):313-8. PubMed ID: 21392164
[TBL] [Abstract][Full Text] [Related]
24. Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.
van den Oever JM; Balkassmi S; Segboer T; Verweij EJ; van der Velden PA; Oepkes D; Bakker E; Boon EM
PLoS One; 2013; 8(12):e84051. PubMed ID: 24391879
[TBL] [Abstract][Full Text] [Related]
25. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
[TBL] [Abstract][Full Text] [Related]
26. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study.
Gonen R; Shahar R; Grimpel YI; Chefetz I; Sammar M; Meiri H; Gibor Y
BJOG; 2008 Nov; 115(12):1465-72. PubMed ID: 19035985
[TBL] [Abstract][Full Text] [Related]
27. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
[TBL] [Abstract][Full Text] [Related]
28. Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences.
Hromadnikova I; Kotlabova K; Krofta L; Hron F
Tumour Biol; 2017 Apr; 39(4):1010428317697548. PubMed ID: 28381180
[TBL] [Abstract][Full Text] [Related]
29. Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free β-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia.
Lai J; Pinas A; Poon LC; Agathokleous M; Nicolaides KH
Fetal Diagn Ther; 2013; 33(3):164-72. PubMed ID: 23445908
[TBL] [Abstract][Full Text] [Related]
30. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.
Akolekar R; Syngelaki A; Beta J; Kocylowski R; Nicolaides KH
Prenat Diagn; 2009 Dec; 29(12):1103-8. PubMed ID: 19777530
[TBL] [Abstract][Full Text] [Related]
31. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
[TBL] [Abstract][Full Text] [Related]
32. Early non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCR.
Kolialexi A; Tounta G; Apostolou P; Vrettou C; Papantoniou N; Kanavakis E; Antsaklis A; Mavrou A
Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):34-7. PubMed ID: 22261468
[TBL] [Abstract][Full Text] [Related]
33. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
[TBL] [Abstract][Full Text] [Related]
34. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.
Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482
[TBL] [Abstract][Full Text] [Related]
35. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients.
Nishizawa H; Pryor-Koishi K; Suzuki M; Kato T; Kogo H; Sekiya T; Kurahashi H; Udagawa Y
Mol Hum Reprod; 2008 Oct; 14(10):595-602. PubMed ID: 18805800
[TBL] [Abstract][Full Text] [Related]
37. Cell-free fetal DNA in maternal circulation after chorionic villous sampling.
Di Tommaso M; Seravalli V; Salvianti F; Bussani C; Pasquini L; Cordisco A; Pinzani P
Prenat Diagn; 2013 Jul; 33(7):695-9. PubMed ID: 23658144
[TBL] [Abstract][Full Text] [Related]
38. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
Bersinger NA; Ødegård RA
Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
[TBL] [Abstract][Full Text] [Related]
39. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
[TBL] [Abstract][Full Text] [Related]
40. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction.
Karapetian АО; Baev ОR; Sadekova АА; Krasnyi АМ; Sukhikh GT
Reprod Sci; 2021 May; 28(5):1563-1569. PubMed ID: 33475978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
